• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在预测新诊断胶质母细胞瘤的生存率方面,临床参数比基于扩散和灌注的MRI参数更为重要。

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.

作者信息

Burth Sina, Kickingereder Philipp, Eidel Oliver, Tichy Diana, Bonekamp David, Weberling Lukas, Wick Antje, Löw Sarah, Hertenstein Anne, Nowosielski Martha, Schlemmer Heinz-Peter, Wick Wolfgang, Bendszus Martin, Radbruch Alexander

机构信息

Department of Neuroradiology, University of Heidelberg Medical Center, Heidelberg, Germany (S.B., P.K., O.E., D.B., L.W., M.B., A.R.); Division of Bioststatistics, German Cancer Research Center, Heidelberg, Germany (D.T.); Department of Neurology, University of Heidelberg Medical Center, Heidelberg, Germany (A.W., S.L., A.H., W.W.); Department of Neurology, Innsbruck Medical University, Innsbruck, Austria (M.N.); Department of Radiology, German Cancer Research Center, Heidelberg, Germany (H.S.).

出版信息

Neuro Oncol. 2016 Dec;18(12):1673-1679. doi: 10.1093/neuonc/now122. Epub 2016 Jun 13.

DOI:10.1093/neuonc/now122
PMID:27298312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5744248/
Abstract

BACKGROUND

The purpose of this study was to determine the relevance of clinical data, apparent diffusion coefficient (ADC), and relative cerebral blood volume (rCBV) from dynamic susceptibility contrast (DSC) perfusion and the volume transfer constant (k) from dynamic contrast-enhanced (DCE) perfusion for predicting overall survival (OS) and progression-free survival (PFS) in newly diagnosed treatment-naïve glioblastoma patients.

METHODS

Preoperative MR scans including standardized contrast-enhanced T1 (cT1), T2 - fluid-attenuated inversion recovery (FLAIR), ADC, DSC, and DCE of 125 patients with subsequent histopathologically confirmed glioblastoma were performed on a 3 Tesla MRI scanner. ADC, DSC, and DCE parameters were analyzed in semiautomatically segmented tumor volumes on contrast-enhanced (CE) cT1 and hyperintense signal changes on T2 FLAIR (ED). Univariate and multivariable Cox regression analyses including age, sex, extent of resection (EOR), and KPS were performed to assess the influence of each parameter on OS and PFS.

RESULTS

Univariate Cox regression analysis demonstrated a significant association of age, KPS, and EOR with PFS and age, KPS, EOR, lower ADC, and higher rCBV with OS. Multivariable analysis showed independent significance of male sex, KPS, EOR, and increased rCBV for PFS, and age, sex, KPS, and EOR for OS.

CONCLUSIONS

MRI parameters help to predict OS in a univariate Cox regression analysis, and increased rCBV is associated with shorter PFS in the multivariable model. In summary, however, our findings suggest that the relevance of MRI parameters is outperformed by clinical parameters in a multivariable analysis, which limits their prognostic value for survival prediction at the time of initial diagnosis.

摘要

背景

本研究的目的是确定临床数据、表观扩散系数(ADC)、动态磁敏感对比(DSC)灌注的相对脑血容量(rCBV)以及动态对比增强(DCE)灌注的容积转运常数(k)对新诊断的未经治疗的胶质母细胞瘤患者总生存期(OS)和无进展生存期(PFS)预测的相关性。

方法

对125例随后经组织病理学确诊为胶质母细胞瘤的患者,在3特斯拉MRI扫描仪上进行术前磁共振扫描,包括标准化对比增强T1(cT1)、T2加权液体衰减反转恢复序列(FLAIR)、ADC、DSC和DCE。在对比增强(CE)cT1上半自动分割的肿瘤体积以及T2 FLAIR上的高信号变化(ED)中分析ADC、DSC和DCE参数。进行单因素和多因素Cox回归分析,包括年龄、性别、切除范围(EOR)和KPS,以评估每个参数对OS和PFS的影响。

结果

单因素Cox回归分析显示,年龄、KPS和EOR与PFS显著相关,年龄、KPS、EOR、较低的ADC和较高的rCBV与OS显著相关。多因素分析显示,男性、KPS、EOR和rCBV升高对PFS具有独立意义,年龄、性别、KPS和EOR对OS具有独立意义。

结论

在单因素Cox回归分析中,MRI参数有助于预测OS,在多变量模型中,rCBV升高与较短的PFS相关。然而,总的来说,我们的研究结果表明,在多变量分析中,MRI参数的相关性不如临床参数,这限制了它们在初始诊断时对生存预测的预后价值。

相似文献

1
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.在预测新诊断胶质母细胞瘤的生存率方面,临床参数比基于扩散和灌注的MRI参数更为重要。
Neuro Oncol. 2016 Dec;18(12):1673-1679. doi: 10.1093/neuonc/now122. Epub 2016 Jun 13.
2
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.新诊断胶质母细胞瘤患者的总生存期与对比增强灌注MRI的相关性:基于T1和T2(*)的团注技术个体内匹配比较
J Magn Reson Imaging. 2015 Jul;42(1):87-96. doi: 10.1002/jmri.24756. Epub 2014 Sep 22.
3
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.表观扩散系数和肿瘤体积测量有助于对接受贝伐单抗治疗的复发性多形性胶质母细胞瘤患者的无进展生存期进行分层。
Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8.
4
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.相对脑血容量是复发性胶质母细胞瘤中贝伐单抗疗效的一种潜在预测性影像生物标志物。
Neuro Oncol. 2015 Aug;17(8):1139-47. doi: 10.1093/neuonc/nov028. Epub 2015 Mar 9.
5
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.使用放化疗期间的时相灌注变化预测胶质母细胞瘤患者的生存和进展。
Magn Reson Imaging. 2020 May;68:106-112. doi: 10.1016/j.mri.2020.01.012. Epub 2020 Jan 28.
6
Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.多参数磁共振成像在对比增强和非增强成分的扩散和灌注在胶质母细胞瘤患者中的应用。
Radiology. 2017 Jul;284(1):180-190. doi: 10.1148/radiol.2017160150. Epub 2017 Feb 27.
7
Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.室管膜接触与胶质母细胞瘤患者的存活率降低和瘤周血供增加有关。
J Neurosurg. 2018 Oct 19;131(3):717-723. doi: 10.3171/2018.5.JNS18340.
8
Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.术前灌注偏度和峰度是新诊断胶质母细胞瘤部分切除术后无进展生存期的潜在预测指标。
Korean J Radiol. 2016 Jan-Feb;17(1):117-26. doi: 10.3348/kjr.2016.17.1.117. Epub 2016 Jan 6.
9
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.脑胶质瘤的放射组学分析:建立一种影像学预测方法,用于评估患者生存情况,与现有的临床和影像学风险模型相比,其预测性能得到改善。
Radiology. 2016 Sep;280(3):880-9. doi: 10.1148/radiol.2016160845. Epub 2016 Jun 20.
10
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.影像生物标志物指导的恶性脑胶质瘤抗血管生成治疗。
Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018.

引用本文的文献

1
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [F]FET PET/MRI study.动态对比增强血容量成像在疑似复发性或残留性胶质母细胞瘤患者中的附加预后价值——一项混合[F]FET PET/MRI研究
Neurooncol Adv. 2024 Nov 18;6(1):vdae196. doi: 10.1093/noajnl/vdae196. eCollection 2024 Jan-Dec.
2
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting promoter methylation and prognostic value in newly diagnosed patients with glioblastoma.动态磁敏感对比增强灌注磁共振成像参数在预测新诊断胶质母细胞瘤患者启动子甲基化及预后价值中的应用
Oncol Lett. 2024 Oct 14;28(6):610. doi: 10.3892/ol.2024.14741. eCollection 2024 Dec.
3
Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes.具有世界卫生组织2/3级组织学特征的异柠檬酸脱氢酶1/2野生型成人星形细胞瘤:分子重新分类、预后因素及临床结果
Biomedicines. 2024 Apr 18;12(4):901. doi: 10.3390/biomedicines12040901.
4
Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type.胶质母细胞瘤IDH野生型中,液体衰减反转恢复序列(FLAIR)图像上高信号病变的表观扩散系数(ADC)与端粒酶逆转录酶(TERT)启动子突变状态的相关性
Surg Neurol Int. 2024 Mar 29;15:108. doi: 10.25259/SNI_63_2024. eCollection 2024.
5
Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.基于聚类的胶质母细胞瘤预后预测:基于弥散和灌注相似性揭示异质性。
Neuro Oncol. 2024 Jun 3;26(6):1099-1108. doi: 10.1093/neuonc/noad259.
6
Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.2021 年世界卫生组织分级 3 和 4 级成人型弥漫性胶质瘤中异柠檬酸脱氢酶突变的评估与 18F-氟咪索硝唑 PET。
Jpn J Radiol. 2023 Nov;41(11):1255-1264. doi: 10.1007/s11604-023-01450-x. Epub 2023 May 23.
7
Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future Perspectives.成人原发性脑肿瘤的磁共振成像:现状与未来展望。
Biomedicines. 2023 Jan 26;11(2):364. doi: 10.3390/biomedicines11020364.
8
Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy.放疗前的灌注磁共振成像(Perfusion MR)是高级别胶质瘤在质子和碳离子放疗后生存的有力预测指标。
Ann Transl Med. 2022 Nov;10(22):1199. doi: 10.21037/atm-20-1646.
9
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.脑弥漫性胶质瘤的血流动力学成像 - 第二部分:分子关联、治疗效果监测、预后及未来方向
Cancers (Basel). 2022 Mar 5;14(5):1342. doi: 10.3390/cancers14051342.
10
Preoperative Apparent Diffusion Coefficient of Peritumoral Lesion Associate with Recurrence in Patients with Glioblastoma.术前肿瘤周围病变的表观扩散系数与胶质母细胞瘤患者的复发相关。
Neurol Med Chir (Tokyo). 2022 Jan 15;62(1):28-34. doi: 10.2176/nmc.oa.2021-0182. Epub 2021 Oct 27.

本文引用的文献

1
Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma.贝伐单抗治疗复发性胶质母细胞瘤中肿瘤氧合的评估及其对治疗反应的影响。
J Cereb Blood Flow Metab. 2017 Feb;37(2):485-494. doi: 10.1177/0271678X16630322. Epub 2016 Jul 21.
2
MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.基于灌注 MRI 的贝伐珠单抗治疗复发性胶质母细胞瘤的血流动力学参数反应映射。
Radiology. 2016 May;279(2):542-52. doi: 10.1148/radiol.2015151172. Epub 2015 Nov 16.
3
Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features.TCGA-GBM数据集中的全自动胶质母细胞瘤分割:预后及与VASARI特征的相关性。
Sci Rep. 2015 Nov 18;5:16822. doi: 10.1038/srep16822.
4
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.异柠檬酸脱氢酶(IDH)突变状态与一种独特的缺氧/血管生成转录组特征相关,该特征在人类胶质瘤中可通过相对脑血容量(rCBV)成像进行非侵入性预测。
Sci Rep. 2015 Nov 5;5:16238. doi: 10.1038/srep16238.
5
Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma.磁共振扩散与灌注成像联合可视化在胶质母细胞瘤中的预后价值
J Neurooncol. 2016 Feb;126(3):463-72. doi: 10.1007/s11060-015-1982-z. Epub 2015 Oct 30.
6
Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.结合异柠檬酸脱氢酶1(IDH1)状态的放射学特征用于预测胶质母细胞瘤患者的生存结局
Neuro Oncol. 2016 Apr;18(4):589-97. doi: 10.1093/neuonc/nov239. Epub 2015 Sep 25.
7
Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.胶质母细胞瘤的预后影像生物标志物:基于多区域和磁共振图像定量分析的开发与独立验证
Radiology. 2016 Feb;278(2):546-53. doi: 10.1148/radiol.2015150358. Epub 2015 Sep 4.
8
The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.术前动态对比增强磁共振成像直方图分析在胶质母细胞瘤患者中的附加预后价值:总生存期和无进展生存期分析
AJNR Am J Neuroradiol. 2015 Dec;36(12):2235-41. doi: 10.3174/ajnr.A4449. Epub 2015 Sep 3.
9
Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.磁共振图像特征可识别具有不同分子通路活性的胶质母细胞瘤表型亚型。
Sci Transl Med. 2015 Sep 2;7(303):303ra138. doi: 10.1126/scitranslmed.aaa7582.
10
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.临床试验中标准化脑肿瘤成像方案的共识性建议。
Neuro Oncol. 2015 Sep;17(9):1188-98. doi: 10.1093/neuonc/nov095. Epub 2015 Aug 5.